On October 15, Jointown Pharmaceutical Group (stock code 600998.SH) announced that the company recently received the 'Acceptance Registration Notice' issued by the National Interbank Funding Center (referred to as the 'trader association'), with the serial number 'NIFC Note [2024] ABN118', accepting the registration of assets-backed commercial paper with a registered amount of 2 billion yuan. The registration quota is valid for 2 years from the date of the notification, underwritten by China Zheshang Bank Co., Ltd. During the valid registration period, the company can issue assets-backed commercial paper in installments and renewals multiple times. The initial issuance should be completed within 6 months after registration, with subsequent issuances filed with the trader association. After the issuance is completed, the company will disclose the issuance results through channels approved by the trader association.